Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (681-690 of 993) with videos related to

Pageof 100
Sort By:
BJU International|October 28, 2024
Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancerMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
International Urology and Nephrology|July 15, 2022
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
International Urology and Nephrology|November 19, 2021
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostateFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Clinical Genitourinary Cancer|May 26, 2022
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer PatientsFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Urology|January 28, 2015
Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patientsJesse D Sammon, Rana R McKay, Simon P Kim, et al.
The Lancet. Oncology|February 22, 2015
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trialFred Saad, Karim Fizazi, Viorel Jinga, et al.
European Urology Focus|October 4, 2024
Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary BladderMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
The Prostate|September 15, 2021
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
Frontiers in Oncology|December 10, 2021
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer PatientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
The Prostate|February 28, 2022
Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancerFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Pageof 100

Showing results (681-690 of 993) with videos related to

Sort By:
Pageof 100
BJU International|October 28, 2024
Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancerMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
International Urology and Nephrology|July 15, 2022
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
International Urology and Nephrology|November 19, 2021
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostateFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Clinical Genitourinary Cancer|May 26, 2022
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer PatientsFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Urology|January 28, 2015
Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patientsJesse D Sammon, Rana R McKay, Simon P Kim, et al.
The Lancet. Oncology|February 22, 2015
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trialFred Saad, Karim Fizazi, Viorel Jinga, et al.
European Urology Focus|October 4, 2024
Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary BladderMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
The Prostate|September 15, 2021
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
Frontiers in Oncology|December 10, 2021
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer PatientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
The Prostate|February 28, 2022
Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancerFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Pageof 100